Marc Iskowitz, MM&M's editor in chief, discusses a qualitative/quantitative approach to meeting orphan drug marketers' engagement challenge with Michael Carlin, vice president at TrialCard.

MM&M Partner Perspectives

MM&M Partner Perspectives

No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers

JUL 27, 201610 MIN
MM&M Partner Perspectives

No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers

JUL 27, 201610 MIN

Description

Marc Iskowitz, MM&M's editor in chief, discusses a qualitative/quantitative approach to meeting orphan drug marketers' engagement challenge with Michael Carlin, vice president at TrialCard.